Red meat and the associated metabolites, such as trimethylamine-N-oxide (TMAO) [2], are gaining attention, not only for individual health but also for planetary health ( l-carnitine, the active form of dietary carnitine and a driver of TMAO, is emerging as a target for CVD prevention and treatment, because it has an important role in the oxidation of fatty acids and cardiac energy metabolism [3]
Consistent with other chronic progressive diseases, the current findings show that discontinuing effective treatment in people living with obesity resulted in reversal of therapeutic benefit and caused significant weight regain, often back towards the pretreatment bodyweight over time. They say the findings highlight the clinical importance of sustained bodyweight reduction in managing the disease of obesity and maintaining cardiometabolic health
The exclusion criteria that bar these patients from Bridge eligibility (on the logic that their plan already covers GLP-1s for their condition) creates a situation where patients with more severe underlying health profiles may face higher out-of-pocket costs than patients who qualify for Bridge access
it sits alongside it
Research suggests that combining these peptides can further enhance cellular repair mechanisms, speed up tissue regeneration, and reduce inflammation
In clinical studies, it was found that typically one could shed 4 percent of their weight in a month and up to 6 percent in two months